Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6

被引:395
作者
Häcker, H
Vabulas, RM
Takeuchi, O
Hoshino, K
Akira, S
Wagner, H
机构
[1] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany
[2] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka 5650871, Japan
关键词
Toll; signal transduction; CpG-DNA; interleukin; 12; mice; knockout;
D O I
10.1084/jem.192.4.595
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Transition of immature antigen presenting cells (APCs) to the state of professional APCs is essential for initiation of cell-mediated immune responses to pathogens. Signal transduction via molecules of the Toll-like receptor (TLR)/interleukin 1 receptor (IL-1R) pathway is critical for activation of APCs either by pathogen-derived pattern ligands like lipopolysaccharides (LPS) or by CD40 ligation through T helper cells. The capacity of bacterial DNA (CpG-DNA) to induce APCs to differentiate into professional APCs represents an interesting discovery. However, the signaling pathways involved are poorly understood. Here we show that CpG-DNA activates the TLR/IL-1R signaling pathway via the molecules myeloid differentiation marker 88 (MyD88) and tumor necrosis factor receptor-associated factor 6 (TRAF6), leading to activation of kinases of the I kappa B kinase complex and the c-jun NH2-terminal kinases. Moreover, cells of TLR2- and TLR4-deficient mice are activated by CpG-DNA, whereas cells of MyD88-deficient mice do not respond. The data suggest that CpG-DNA initiates signaling via the TLR/IL-1R pathway in APCs in a manner similar to LPS and to T helper cell-mediated CD40 ligation. Activation of the TLR/IL-1R signaling pathway by foreign bacterial DNA may be one way to initiate innate defense mechanisms against infectious pathogens in vivo.
引用
收藏
页码:595 / 600
页数:6
相关论文
共 30 条
[1]   Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function [J].
Adachi, O ;
Kawai, T ;
Takeda, K ;
Matsumoto, M ;
Tsutsui, H ;
Sakagami, M ;
Nakanishi, K ;
Akira, S .
IMMUNITY, 1998, 9 (01) :143-150
[2]   Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain [J].
Baud, V ;
Liu, ZG ;
Bennett, B ;
Suzuki, N ;
Xia, Y ;
Karin, M .
GENES & DEVELOPMENT, 1999, 13 (10) :1297-1308
[3]   MyD88, an adapter protein involved in interleukin-1 signaling [J].
Burns, K ;
Martinon, F ;
Esslinger, C ;
Pahl, H ;
Schneider, P ;
Bodmer, JL ;
Di Marco, F ;
French, L ;
Tschopp, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (20) :12203-12209
[4]   TARF6 is a signal transducer for interleukin-1 [J].
Cao, ZD ;
Xiong, J ;
Takeuchi, M ;
Kurama, T ;
Goeddel, DV .
NATURE, 1996, 383 (6599) :443-446
[5]   RETRIEVAL OF TGN PROTEINS FROM THE CELL-SURFACE REQUIRES ENDOSOMAL ACIDIFICATION [J].
CHAPMAN, RE ;
MUNRO, S .
EMBO JOURNAL, 1994, 13 (10) :2305-2312
[6]   JNK2 and IKKβ are required for activating the innate response to viral infection [J].
Chu, WM ;
Ostertag, D ;
Li, ZW ;
Chang, LF ;
Chen, Y ;
Hu, YL ;
Williams, B ;
Perrault, J ;
Karin, M .
IMMUNITY, 1999, 11 (06) :721-731
[7]   The double-stranded RNA-dependent protein kinase PKR: Structure and function [J].
Clemens, MJ ;
Elia, A .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1997, 17 (09) :503-524
[8]   Cell type-specific activation of mitogen-activated protein kinases by CpG-DNA controls interleukin-12 release from antigen-presenting cells [J].
Häcker, H ;
Mischak, H ;
Häcker, G ;
Eser, S ;
Prenzel, N ;
Ullrich, A ;
Wagner, H .
EMBO JOURNAL, 1999, 18 (24) :6973-6982
[9]  
Hoshino K, 1999, J IMMUNOL, V162, P3749
[10]   Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region [J].
Ishida, T ;
Mizushima, S ;
Azuma, S ;
Kobayashi, N ;
Tojo, T ;
Suzuki, K ;
Aizawa, S ;
Watanabe, T ;
Mosialos, G ;
Kieff, E ;
Yamamoto, T ;
Inoue, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) :28745-28748